This HTML5 document contains 125 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46569295
rdf:type
wikibase:Item
schema:description
bilimsel makale 2011 nî lūn-bûn 2011年学术文章 scientific article published in February 2011 artikull shkencor мақолаи илмӣ 2011年学术文章 2011年學術文章 מאמר מדעי наукова стаття, опублікована в лютому 2011 2011年学术文章 2011년 논문 научни чланак artigo científico artykuł naukowy vitskapeleg artikkel artikel ilmiah مقالة علمية نشرت في فبراير 2011 artigo científico 2011年學術文章 επιστημονικό άρθρο article scientific articolo scientifico 2011年の論文 2011年學術文章 บทความทางวิทยาศาสตร์ naučni članak 2011年学术文章 wissenschaftlicher Artikel научная статья article científic 2011年學術文章 teaduslik artikkel vitenskapelig artikkel tudományos cikk 2011年学术文章 wetenschappelijk artikel scientific article published in February 2011 artikulong pang-agham 2011年學術文章 article scientifique vědecký článek научна статия научни чланак scienca artikolo artículo científico publicado en 2011 artículu científicu articol științific scientific article published in February 2011 vedecký článok სამეცნიერო სტატია bài báo khoa học videnskabelig artikel tieteellinen artikkeli 2011年学术文章 artigo científico ফেব্রুয়ারি ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vetenskaplig artikel
p:P577
wds:Q46569295-1CB24B99-FCD4-4CBF-AA83-6CBD12CEAACC
wdt:P577
2011-02-01T00:00:00Z
p:P2860
wds:Q46569295-0A17A3D3-198A-4788-9C2A-90C1F7732A01 wds:Q46569295-14CD259B-7382-4E5B-9A08-90B98DF0F4B2 wds:Q46569295-2050F61E-0EA5-4246-8CA4-27BCE1B4A4B0 wds:Q46569295-22A01897-0D79-4F2E-A510-845EBC0CE916 wds:Q46569295-F5787028-E904-4205-B4F4-D76EF9C1F585 wds:Q46569295-F5CEA31E-9652-4357-A926-E2C566674E2D wds:Q46569295-F8A9DA2D-E4ED-4F48-8AD7-8DAF7EDB35E3 wds:Q46569295-FAD76B4B-D9AB-4708-8C82-ABF47B54E7A4 wds:Q46569295-80E8063F-6AA4-4DBD-98CF-B019557EFD38 wds:Q46569295-943F7B7E-0A26-4C67-8CD6-84C98B012F84 wds:Q46569295-94F9168C-F40D-452E-AB1A-24DCD5CBB02F wds:Q46569295-9EA2D5F2-62A7-40A1-920E-5139D7790B73 wds:Q46569295-BFA9C083-1018-4716-864F-ECD47A62E301 wds:Q46569295-2470F432-5C06-4817-B79C-89689076385F wds:Q46569295-36AEB5B1-817D-41CD-A67E-B188B2AA3890 wds:Q46569295-6C5DDD7C-3DFC-443B-84A7-F632CD29BEC4 wds:Q46569295-7C472EAC-CF1C-44C6-88EC-F20D2800EE3D
wdt:P2860
wd:Q27860949 wd:Q37583380 wd:Q34445111 wd:Q42980356 wd:Q34575356 wd:Q58033213 wd:Q43038193 wd:Q29616215 wd:Q36971062 wd:Q29547886 wd:Q27473066 wd:Q27860901 wd:Q28362246 wd:Q42541662 wd:Q27860799 wd:Q42985188 wd:Q34278946
p:P2093
wds:Q46569295-09D42961-6C48-4E16-B9F3-7A685B797FE5 wds:Q46569295-6FF03CB5-B83E-410F-8E07-ACDEFFEC2CEB
wdt:P2093
K Hagen P Rosenberg
rdfs:label
Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection
skos:prefLabel
Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection
schema:name
Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection
p:P1476
wds:Q46569295-776113D7-F0BD-488D-85C8-9615F72D038D
wdt:P1476
Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection
p:P304
wds:Q46569295-238F79B3-68CC-4825-A278-3820D0EFD98B
wdt:P304
129-134
p:P31
wds:Q46569295-08DD3F43-7BB0-459E-8A28-1FB27A5104BA
wdt:P31
wd:Q13442814
p:P921
wds:Q46569295-9FE24E1A-E420-4117-8C67-A5DCC5A3FA1E
wdt:P921
wd:Q421862
p:P698
wds:Q46569295-8933E955-7D65-40E0-A172-C8F4DD543E6A
wdtn:P698
n11:20196801
wdt:P698
20196801
p:P1433
wds:Q46569295-ABFD924C-870D-4D55-BBF0-8630FE088B5C
wdt:P1433
wd:Q15749962
p:P433
wds:Q46569295-566CFF71-751B-446C-BE4F-28E7D53B7B93
p:P478
wds:Q46569295-76EBF1E2-A2A2-4FB7-A2D3-25529AB21F7A
wdt:P433
2
wdt:P478
18
p:P356
wds:Q46569295-BFC76A46-0485-427B-A61A-C1072A273FCE
wdtn:P356
n10:J.1365-2893.2010.01288.X
wdt:P356
10.1111/J.1365-2893.2010.01288.X